These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36133911)

  • 1. Effect of Conbercept Treatment on Macular Edema and Microvascular Structure in Eyes with Retinal Vein Occlusions.
    Ding X; Wang Y; Zou B; Zang D; Hao Y
    Int J Gen Med; 2022; 15():7311-7318. PubMed ID: 36133911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Microvascular Structure Changes after Conbercept Treatment on Macular Edema Secondary to Retinal Vein Occlusion.
    Song W; Jiao W; Li F; Ma A; Zhao B
    Biomed Res Int; 2020; 2020():9046781. PubMed ID: 32685542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular changes after conbercept therapy in central retinal vein occlusion analyzed by optical coherence tomography angiography.
    Deng Y; Zhong QW; Zhang AQ; Cai XJ; Lu MZ; Zhang SC; Su LS; Chen H; Lin Y; Sun LM; Chen GD; Zhong LT; Jin CJ; Chi W
    Int J Ophthalmol; 2019; 12(5):802-808. PubMed ID: 31131240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Analysis of Retinal Microvascular Changes after Conbercept Therapy in Branch Retinal Vein Occlusion Using Optical Coherence Tomography Angiography.
    Deng Y; Cai X; Zhang S; Su L; Chen H; Lin Y; Sun L; Chen G; Zhong L; Jin C; Chi W
    Ophthalmologica; 2019; 242(2):69-80. PubMed ID: 31112969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conbercept improves macular microcirculation and retinal blood supply in the treatment of nonischemic branch retinal vein occlusion macular edema.
    Huang Y; Linghu M; Hu W; Huang X
    J Clin Lab Anal; 2022 Dec; 36(12):e24774. PubMed ID: 36408725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept.
    Zhang Q; Hou Y; Cao X; Zhang R; Liu Y; Wei C; Wu C; Mei L; Zhang P
    BMC Ophthalmol; 2021 Nov; 21(1):402. PubMed ID: 34809591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular Changes After Conbercept Intravitreal Injection of PDR With or Without Center-Involved Diabetic Macular Edema Analyzed by OCTA.
    Lin W; Feng M; Liu T; Wang Q; Wang W; Xie X; Li W; Guan J; Ma Z; Liu T; Zhou Q
    Front Med (Lausanne); 2022; 9():797087. PubMed ID: 35391880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Choroidal Thickness, Foveal Avascular Zone, and Macular Capillary Density in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Ranibizumab or Aflibercept-A Prospective Study.
    Huang YT; Wang I; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Bair H; Lin JM; Chen WL; Chen CH; Wu WC; Tsai YY
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography angiography microvascular findings in macular edema due to central and branch retinal vein occlusions.
    Mastropasqua R; Toto L; Di Antonio L; Borrelli E; Senatore A; Di Nicola M; Di Martino G; Ciancaglini M; Carpineto P
    Sci Rep; 2017 Jan; 7():40763. PubMed ID: 28098203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION.
    Sun Z; Zhou H; Lin B; Jiao X; Luo Y; Zhang F; Tao S; Wu Q; Ke Z; Liu X
    Retina; 2017 Sep; 37(9):1723-1730. PubMed ID: 27893623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
    Tang F; Qin X; Lu J; Song P; Li M; Ma X
    Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Capillary Plexus as Biomarker of Peripheral Capillary Nonperfusion in Central Retinal Vein Occlusion.
    Battaglia Parodi M; Arrigo A; Antropoli A; Bianco L; Saladino A; Bandello F; Vilela M; Mansour A
    Ophthalmol Sci; 2023 Jun; 3(2):100267. PubMed ID: 36824600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
    Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
    Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Macular Microvascular Structure in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Antivascular Endothelial Growth Factor for One Year.
    Song S; Yu X; Zhang P; Dai H
    J Ophthalmol; 2021; 2021():6645452. PubMed ID: 34055397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
    Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 18. Optical coherence tomography angiography for macular microvessels in ischemic branch retinal vein occlusion treated with conbercept: predictive factors for the prognosis.
    Tang L; Sun GL; Zhao Y; Yang TT; Yao J
    Int J Ophthalmol; 2023; 16(12):2049-2055. PubMed ID: 38111937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
    Kim M; Jeong S; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
    Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.